Literature DB >> 3572976

Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compounds.

B E Maryanoff, S O Nortey, J F Gardocki, R P Shank, S P Dodgson.   

Abstract

Novel sugar sulfamate 1 (McN-4853, topiramate) has been found to exhibit potent anticonvulsant activity analogous to that of phenytoin. In the maximal electroshock seizure test, orally at 2 h in mice, 1 had an ED50 of 39 mg/kg. Orally, 1 had a duration of action in excess of 8 h. Other aspects of the pharmacology of 1, as well as neurochemistry and carbonic anhydrase inhibition, are discussed. The conformational behavior of 1 in solution and in the solid state is discussed. A series of analogues of 1 were synthesized and examined for anticonvulsant properties.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572976     DOI: 10.1021/jm00388a023

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  27 in total

1.  Deoxysugars as antituberculars and alpha-mannosidase inhibitors.

Authors:  Vivek Kashyap; Smriti Sharma; Vinayak Singh; Sandeep K Sharma; Mohammad Saquib; Ranjana Srivastava; Arun K Shaw
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).

Authors:  David F McComsey; Virginia L Smith-Swintosky; Michael H Parker; Douglas E Brenneman; Ewa Malatynska; H Steve White; Brian D Klein; Karen S Wilcox; Michael E Milewski; Mark Herb; Michael F A Finley; Yi Liu; Mary Lou Lubin; Ning Qin; Allen B Reitz; Bruce E Maryanoff
Journal:  J Med Chem       Date:  2013-11-11       Impact factor: 7.446

3.  Metabolism and excretion of the antiepileptic/antimigraine drug, Topiramate in animals and humans.

Authors:  G W Caldwell; W N Wu; J A Masucci; L A McKown; D Gauthier; W J Jones; G C Leo; B E Maryanoff
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

4.  Application of silver N-heterocyclic carbene complexes in O-glycosidation reactions.

Authors:  Ian J Talisman; Vineet Kumar; Jeffrey R Deschamps; Mark Frisch; Sanjay V Malhotra
Journal:  Carbohydr Res       Date:  2011-08-02       Impact factor: 2.104

5.  Topiramate-antagonism of L-glutamate-induced paroxysms in planarians.

Authors:  Robert B Raffa; Kristin E Finno; Christopher S Tallarida; Scott M Rawls
Journal:  Eur J Pharmacol       Date:  2010-09-19       Impact factor: 4.432

6.  Room Temperature Activation of Aryloxysulfonyl Azides by [Co(II)(TPP)] for Selective Radical Aziridination of Alkenes via Metalloradical Catalysis.

Authors:  Velusamy Subbarayan; Li-Mei Jin; Cui Xin; X Peter Zhang
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

7.  Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex.

Authors:  V Echeverry-Alzate; E Giné; K M Bühler; J Calleja-Conde; P Olmos; M A Gorriti; R Nadal; F Rodríguez de Fonseca; J A López-Moreno
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

8.  Antiischemic effects of topiramate in a transient global forebrain ischemia model: a neurochemical, histological, and behavioral evaluation.

Authors:  S H Khan; Sandra Lea Wright; Ali Banigesh; Hiro Miyashita; Kathryn Todd; Susan Jean Hemmings; Tom Wishart; Ashfaq Shuaib
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 9.  Pharmacokinetic interactions of topiramate.

Authors:  Meir Bialer; Dennis R Doose; Bindu Murthy; Christopher Curtin; Shean-Sheng Wang; Roy E Twyman; Stefan Schwabe
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

10.  Topiramate in the treatment of partial and generalized epilepsy.

Authors:  Edward Faught
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.